TLX

Bullish

Telix Pharmaceuticals clear FDA panel milestone, shares react in oncology sector context

Telix Pharmaceuticals (AU000000TLX2) is gaining investor attention following its progress in the FDA regulatory pathway for its radiopharmaceutical pi...

Ad-hoc-news.de 6 days ago 0

Bullish

Prediction: I think Telix shares could double in value in 2026. Here’s why

Telix Pharmaceuticals (ASX: TLX) shares have rebounded significantly after dipping to a three-year low in February, driven by positive regulatory anno...

The Motley Fool Australia 3 weeks ago 0